Search Results - "Musuamba, F. T."

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) by Musuamba, FT, Manolis, E, Holford, N, Cheung, SYA, Friberg, LE, Ogungbenro, K, Posch, M, Yates, JWT, Berry, S, Thomas, N, Corriol‐Rohou, S, Bornkamp, B, Bretz, F, Hooker, AC, Van der Graaf, PH, Standing, JF, Hay, J, Cole, S, Gigante, V, Karlsson, K, Dumortier, T, Benda, N, Serone, F, Das, S, Brochot, A, Ehmann, F, Hemmings, R, Rusten, I Skottheim

“…Inadequate dose selection for confirmatory trials is currently still one of the most challenging issues in drug development, as illustrated by high rates of…”
Get full text

Prediction of Disease Progression, Treatment Response and Dropout in Chronic Obstructive Pulmonary Disease (COPD) by Musuamba, F. T., Teutonico, D., Maas, H. J., Facius, A., Yang, S., Danhof, M., Della Pasqua, O.

“…Purpose Drug development in chronic obstructive pulmonary disease (COPD) has been characterised by unacceptably high failure rates. In addition to the poor…”
Get full text

PREDICTIVE PERFORMANCES OF DIFFERENT THERAPEUTIC DRUG MONITORING APPROACHES TO ASSESS TACROLIMUS AND MYCOPHENOLIC ACID EXPOSURE by Musuamba, FT, Mourad, M., Haufroid, V., Bosmans, JL, Sennesael, JJ, Verbeeck, RK, Wallemacq, P.

“…Objective: Mycophenolic acid (MPA) and Tacrolimus (TAC) are immunosuppressive drugs routinely used after solid organ transplantation. MPA and TAC have a rather…”
Get full text

Pharmacokinetics and dosage adjustment in patients with renal dysfunction by Verbeeck, Roger K, Musuamba, Flora T

“…Introduction Chronic kidney disease is a common, progressive illness that is becoming a global public health problem. In patients with kidney dysfunction, the…”
Get full text